JP2011519932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011519932A5 JP2011519932A5 JP2011508521A JP2011508521A JP2011519932A5 JP 2011519932 A5 JP2011519932 A5 JP 2011519932A5 JP 2011508521 A JP2011508521 A JP 2011508521A JP 2011508521 A JP2011508521 A JP 2011508521A JP 2011519932 A5 JP2011519932 A5 JP 2011519932A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticles
- protein
- phase solution
- aqueous phase
- immunogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims 18
- 239000000243 solution Substances 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 11
- 238000000034 method Methods 0.000 claims 10
- 239000008346 aqueous phase Substances 0.000 claims 8
- 239000004094 surface-active agent Substances 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 5
- 150000003904 phospholipids Chemical class 0.000 claims 5
- 239000002904 solvent Substances 0.000 claims 5
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 239000000872 buffer Substances 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229920002494 Zein Polymers 0.000 claims 3
- 230000002209 hydrophobic effect Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 239000005019 zein Substances 0.000 claims 3
- 229940093612 zein Drugs 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 238000005538 encapsulation Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000012071 phase Substances 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000007979 citrate buffer Substances 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 229960000502 poloxamer Drugs 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12713408P | 2008-05-09 | 2008-05-09 | |
| US61/127,134 | 2008-05-09 | ||
| PCT/US2009/002935 WO2009137112A1 (en) | 2008-05-09 | 2009-05-11 | Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014099344A Division JP5851550B2 (ja) | 2008-05-09 | 2014-05-13 | 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011519932A JP2011519932A (ja) | 2011-07-14 |
| JP2011519932A5 true JP2011519932A5 (enExample) | 2012-06-28 |
| JP5546532B2 JP5546532B2 (ja) | 2014-07-09 |
Family
ID=41264904
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508521A Active JP5546532B2 (ja) | 2008-05-09 | 2009-05-11 | 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用 |
| JP2014099344A Active JP5851550B2 (ja) | 2008-05-09 | 2014-05-13 | 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014099344A Active JP5851550B2 (ja) | 2008-05-09 | 2014-05-13 | 非免疫原生の疎水性タンパク質ナノ粒子の形成方法、及びその利用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8669225B2 (enExample) |
| EP (1) | EP2285825B1 (enExample) |
| JP (2) | JP5546532B2 (enExample) |
| KR (1) | KR101616771B1 (enExample) |
| CN (1) | CN102066399B (enExample) |
| AU (1) | AU2009244742B2 (enExample) |
| BR (1) | BRPI0908686B8 (enExample) |
| CA (1) | CA2723563C (enExample) |
| IL (1) | IL209155A (enExample) |
| RU (1) | RU2010146684A (enExample) |
| WO (1) | WO2009137112A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2170283T3 (en) | 2007-06-22 | 2019-04-15 | Univ Texas | CREATION OF STABLE SUBMICRON Peptide OR PROTEIN PARTICLES BY THIN FILM FREEZING |
| US20140234420A1 (en) * | 2008-05-09 | 2014-08-21 | Omathanu P. Perumal | Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions |
| AU2009244742B2 (en) * | 2008-05-09 | 2014-11-06 | South Dakota State University | Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| US8697098B2 (en) | 2011-02-25 | 2014-04-15 | South Dakota State University | Polymer conjugated protein micelles |
| JP5711138B2 (ja) | 2008-11-16 | 2015-04-30 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 高濃度の低粘度懸濁液 |
| CN102958384B (zh) | 2010-06-30 | 2016-02-24 | 荷兰联合利华有限公司 | 包含疏水聚合物和疏水酚类化合物的颗粒 |
| AU2011278186B2 (en) | 2010-07-16 | 2015-02-05 | Centro Nacional De Tecnologia Y Seguridad Alimentaria, Laboratorio Del Ebro | Nanoparticles for the encapsulation of compounds, the obtaining and uses thereof |
| CN102120823B (zh) * | 2011-01-06 | 2016-08-03 | 鲁传华 | 水溶性玉米朊的合成及在药物制剂中的运用 |
| KR101952599B1 (ko) | 2011-02-25 | 2019-05-22 | 사우스다코타주립대학 | 고분자 컨쥬게이트화된 단백질 마이셀 |
| EP2678007A4 (en) * | 2011-02-25 | 2015-08-12 | Univ South Dakota | PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION |
| AU2012225277A1 (en) * | 2011-03-10 | 2013-09-26 | Board Of Regents, The University Of Texas System | Protein nanoparticle dispersions |
| CA2883080A1 (en) * | 2011-08-26 | 2013-03-07 | Vecoy Nanomedicines Ltd. | Pathogen and substance traps |
| EP2625966A1 (en) | 2012-02-13 | 2013-08-14 | Bionanoplus, S.L. | Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof |
| WO2014005299A1 (en) * | 2012-07-04 | 2014-01-09 | Empire Technology Development Llc | Quantum dot-protein complexes, films, and methods of use |
| KR102045732B1 (ko) * | 2012-12-28 | 2019-11-18 | 엘지디스플레이 주식회사 | 온도감응형 계면활성제를 이용한 수용성 나노입자의 제조방법 |
| CN105682646A (zh) * | 2013-06-04 | 2016-06-15 | 南达科他州立大学 | 用于口服药物递送的新型核-壳纳米颗粒 |
| IL228528A (en) | 2013-09-17 | 2015-01-29 | Technion Res & Dev Foundation | Potato-based nanoparticles |
| WO2016057799A1 (en) * | 2014-10-09 | 2016-04-14 | Therakine | Use of meso-and nanoporous material for surfactant trapping in nanoparticle suspensions |
| WO2018071864A1 (en) | 2016-10-13 | 2018-04-19 | Thomas Jefferson University | Delivery compositions, and methods of making and using same |
| CN110730656B (zh) * | 2017-06-02 | 2022-09-16 | 特一华制药株式会社 | 水难溶性成分增溶胶束及含有该胶束的液体制剂 |
| TWI642685B (zh) * | 2017-07-26 | 2018-12-01 | 中原大學 | 新穎胜肽及其應用 |
| CN109432433A (zh) * | 2018-10-30 | 2019-03-08 | 中国药科大学 | 一种纳米载体的制备方法和用途 |
| CN109730976B (zh) * | 2018-12-24 | 2020-06-09 | 华中科技大学 | 一种基于自由基氧化制备白蛋白纳米粒的方法 |
| CN110251487B (zh) * | 2019-08-01 | 2021-11-02 | 郑州大学 | 一种提高多西他赛载药量和口服生物利用度的醇溶蛋白纳米粒的制备方法及其应用 |
| CN112121019B (zh) * | 2020-09-23 | 2022-05-31 | 合肥工业大学 | 抗氧化型淀粉基糊精复合纳米颗粒及其制备方法与应用 |
| CN115025054B (zh) * | 2022-06-09 | 2023-12-22 | 四川普锐特药业有限公司 | 一种以乳铁蛋白为载体的纳米组合物的制备方法 |
| CN116998582A (zh) * | 2023-08-08 | 2023-11-07 | 扬州大学 | 一种高溶解度油料植物蛋白的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2236521A (en) | 1937-08-12 | 1941-04-01 | Zein Corp Of America | Ink |
| US5330778A (en) | 1988-09-19 | 1994-07-19 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles |
| AU642932B2 (en) * | 1989-11-06 | 1993-11-04 | Alkermes Controlled Therapeutics, Inc. | Protein microspheres and methods of using them |
| US5254673A (en) * | 1991-12-26 | 1993-10-19 | Opta Food Ingredients, Inc. | Purification of zein from corn gluten meal |
| IE80468B1 (en) * | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| MY153295A (en) * | 2004-09-29 | 2015-01-29 | Nestec Sa | Nanoparticulated whey proteins |
| US20070148251A1 (en) | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
| KR20080111033A (ko) * | 2006-03-29 | 2008-12-22 | 후지필름 가부시키가이샤 | 카제인 나노입자 |
| EP2054036B1 (en) * | 2006-07-24 | 2019-12-18 | Singh-Broemer and Company, Inc. | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening |
| CN101485629B (zh) * | 2008-01-16 | 2013-01-23 | 沈阳药科大学 | 一种给药系统及其制备方法 |
| AU2009244742B2 (en) * | 2008-05-09 | 2014-11-06 | South Dakota State University | Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| EP2678007A4 (en) * | 2011-02-25 | 2015-08-12 | Univ South Dakota | PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION |
-
2009
- 2009-05-11 AU AU2009244742A patent/AU2009244742B2/en active Active
- 2009-05-11 WO PCT/US2009/002935 patent/WO2009137112A1/en not_active Ceased
- 2009-05-11 EP EP09743099.5A patent/EP2285825B1/en active Active
- 2009-05-11 BR BRPI0908686A patent/BRPI0908686B8/pt active IP Right Grant
- 2009-05-11 CA CA2723563A patent/CA2723563C/en active Active
- 2009-05-11 RU RU2010146684/10A patent/RU2010146684A/ru not_active Application Discontinuation
- 2009-05-11 JP JP2011508521A patent/JP5546532B2/ja active Active
- 2009-05-11 KR KR1020107027648A patent/KR101616771B1/ko active Active
- 2009-05-11 CN CN200980123704.5A patent/CN102066399B/zh active Active
- 2009-05-11 US US12/991,872 patent/US8669225B2/en active Active
-
2010
- 2010-11-04 IL IL209155A patent/IL209155A/en active IP Right Grant
-
2014
- 2014-03-10 US US14/203,476 patent/US9616021B2/en not_active Expired - Fee Related
- 2014-05-13 JP JP2014099344A patent/JP5851550B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011519932A5 (enExample) | ||
| RU2010146684A (ru) | Способ получения неиммуногенных гидрофобных белковых наночастиц и их применения | |
| Rocha et al. | Promising strategies for improving oral bioavailability of poor water-soluble drugs | |
| Sonvico et al. | Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting | |
| Lombardo et al. | Nanotechnologies for intranasal drug delivery: an update of literature | |
| Garbayo et al. | Diagnostic and therapeutic uses of nanomaterials in the brain | |
| Nojoki et al. | Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer’s disease: In vitro, in vivo, and ex vivo evaluations | |
| Xu et al. | RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain | |
| Patel et al. | Nanomedicine for intranasal delivery to improve brain uptake | |
| Xin et al. | PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations | |
| Jampílek et al. | Nanobiotechnology in neurodegenerative diseases | |
| Dimer et al. | Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats | |
| Osmani et al. | Cyclodextrin nanosponges in drug delivery and nanotherapeutics | |
| Pradhan et al. | Nanomodulators that target Alzheimer’s disease: A review | |
| Lakkakula et al. | Alginate‐Based Nanosystems for Therapeutic Applications | |
| Liu et al. | Nanoscale drug formulations for the treatment of Alzheimer's disease progression | |
| CN106727430A (zh) | 一种载药多孔纳米粒子的制备方法 | |
| Ali et al. | Antiviral role of nanomaterials: a material scientist's perspective | |
| JP2019513139A5 (enExample) | ||
| Malhotra et al. | Nanoneuroscience: cutting-edge approach for disease management | |
| Lee et al. | A charge-switched nano-sized polymeric carrier for protein delivery | |
| TWI543778B (zh) | 蛋白質／石墨烯奈米複合藥物載體 | |
| Demina et al. | Development strategies and biopharmaceutical aspects of drug delivery systems | |
| Zhu et al. | Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: In vitro and in vivo evaluation | |
| CN111315399B (zh) | 用于药物递送的葡萄糖敏感性组合物 |